BOSCHI, STEFANO
BOSCHI, STEFANO
ARAG - AREA FINANZA E CONTABILITA'
Personale esterno ed autonomi
11C-Choline PET/CT in hormonal resistant patients after radical prostatectomy
2013 Francesco Ceci, Paolo Castellucci, Riccardo Schiavina, Chiara Fuccio, Stefano Boschi, Daniele Romagnoli, Elena Tabacchi, Marcelo Mamede, Cristina Nanni, Stefano Fanti
11C-Choline PET/CT in patients with biochemical relapse after radical prostatectomy and PSA levels < 0.5 ng/mL
2012 Marcelo Mamede, Paolo Castellucci, Francesco Ceci, Riccardo Schiavina, Stefano Boschi, Valentina Ambrosini, Chiara Fuccio, Annarita Ianniello, Rossella Ferrara, Stefano Fanti
18F-FDG PET early after radiotherapy in lymphoma patients.
2004 CASTELLUCCI P; ZINZANI P; NANNI C; FARSAD M; MORETTI A; ALINARI L; BATTISTA G; PETTINATO C; MARENGO M; BOSCHI S; CANINI R; BACCARANI M.; MONETTI N; FANTI S.
[18F]F-PSMA-1007 Radiolabelling without an On-Site Cyclotron: A Quality Issue
2021 Di Iorio, Valentina; Boschi, Stefano; Sarnelli, Anna; Cuni, Cristina; Bianchini, David; Monti, Manuela; Gorgoni, Giancarlo; Paganelli, Giovanni; Matteucci, Federica; Masini, Carla
Advances in preclinical therapeutics development using small animal imaging and molecular analyses: the gastrointestinal stromal tumors model.
2009 M.A. Pantaleo; L. Landuzzi; G. Nicoletti; C. Nanni; S. Boschi; G. Piazzi; D. Santini; M. Di Battista; P. Castellucci; F. Lodi; S. Fanti; P.-L. Lollini; G. Biasco
An HPLC and UHPLC-HRMS approach to study PSMA-11 instability in aqueous solution
2021 Iudicello, Antonella; Genovese, Filippo; Di Iorio, Valentina; Cicoria, Gianfranco; Boschi, Stefano
Bioavailability of single and multiple doses of a new oral formulation of 5‐ASA in patients with inflammatory bowel disease and healthy volunteers
1994 GIONCHETTI P.; CAMPIERI M.; BELLUZZI A.; BOSCHI S.; BRIGNOLA C.; MIGLIOLI M.; BARBARA L.
C-11 Acetate does not enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma.
2009 Magini G; Farsad M; Frigerio M; Serra C; Colecchia A; Jovine E; Vivarelli M; Feletti V; Golfieri R; Patti C; Fanti S; Franchi R; Lodi F; Boschi S; Bernardi M; Trevisani F.
Comparison of 18F-FACBC and 11C-choline PET/CT in patients with radically treated prostate cancer and biochemical relapse: preliminary results
2013 Cristina Nanni; Riccardo Schiavina; Stefano Boschi; Valentina Ambrosini; Cinzia Pettinato; Eugenio Brunocilla; Giuseppe Martorana; Stefano Fanti
Conventional and novel PET tracers for imaging in oncology in the era of molecular therapy. Review
2008 Pantaleo M.A.; Nannini M.; Maleddu A.; Fanti S.; Ambrosini V.; Nanni C.; Boschi S.; Biasco G.
Detection and localization of prostate cancer: correlation of (11)C-choline PET/CT with histopathologic step-section analysis
2005 Farsad M; Schiavina R; Castellucci P; Nanni C; Corti B; Martorana G; Canini R; Grigioni W; Boschi S; Marengo M; Pettinato C; Salizzoni E; Monetti N; Franchi R; Fanti S.
Effects of new fish oil derivative on fatty acid phospholipid-membrane pattern in a group of Crohn's disease patients
1994 Belluzzi A.; Brignola C.; Campieri M.; Camporesi E.P.; Gionchetti P.; Rizzello F.; Belloli C.; De Simone G.; Boschi S.; Miglioli M.; Barbara L.
Evaluation of Modified PEG-Anilinoquinazoline Derivatives as Potential Agents for EGFR Imaging in Cancer by Small Animal PET.
2010 Pantaleo M.A.; Mishani E.; Nanni C.; Landuzzi L.; Boschi S.; Nicoletti G.; Dissoki S.; Paterini P.; Piccaluga P.P.; Lodi F.; Lollini P.L.; Fanti S.; Biasco G.
Experimental results and related clinical implications of PET detection of epidermal growth factor receptor (EGFr) in cancer
2009 M.A. Pantaleo; M. Nannini; A. Maleddu; S. Fanti; C. Nanni; S. Boschi; F. Lodi; G. Nicoletti; L. Landuzzi; P. L. Lollini; G. Biasco
From radiotracer to radiopharmaceutical: a philosophical approach
2021 Boschi, Stefano; Todde, Sergio
Functional imaging of digestive endocrine tumors.
2007 Fanti S.; Nanni C.; Ambrosini V.; Campana D.; Montini G.C.; Castellucci P.; Di Piezzo D.; Rubello D.; Allegri V.; Tomassetti P.; Boschi S.; Franchi R.
Ga-68-PSMA PET/CT for early restaging prostate cancer. Preliminary results of a prospective trial in patients with biochemical failure after radical therapy and PSA levels< 2 ng/mL
2016 francesco ceci; castellucci paolo; tiziano graziani; cristina fonti; filippo lodi; stefano boschi; stefano fanti
Generator breakthrough and radionuclidic purification in automated synthesis of 68Ga-DOTANOC
2013 Belosi F; Cicoria G; Lodi F; Malizia C; Fanti S; Boschi S; Marengo M.
Is there a role for 11C-choline PET/CT in the early detection of metastatic disease in surgically treated prostate cancer patients with a mild PSA increase <1.5 ng/ml?
2011 Castellucci P.; Fuccio C.; Rubello D.; Schiavina R.; Santi I.; Nanni C.; Allegri V.; Montini G.C.; Ambrosini V.; Boschi S.; Martorana G.; Marzola M.C.; Fanti S.
Molecular imaging and targeted therapies in oncology: new concepts in treatment response assessment. a collection of cases.
2008 Pantaleo MA;Nannini M;Lopci E;Castellucci P;Maleddu A;Lodi F;Nanni C;Allegri V;Astorino M;Brandi G;Di Battista M;Boschi S;Fanti S;Biasco G
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| 11C-Choline PET/CT in hormonal resistant patients after radical prostatectomy | Francesco Ceci, Paolo Castellucci, Riccardo Schiavina, Chiara Fuccio, Stefano Boschi, Daniele Rom...agnoli, Elena Tabacchi, Marcelo Mamede, Cristina Nanni, Stefano Fanti | 2013-01-01 | THE JOURNAL OF NUCLEAR MEDICINE | - | 4.02 Riassunto (Abstract) | - |
| 11C-Choline PET/CT in patients with biochemical relapse after radical prostatectomy and PSA levels < 0.5 ng/mL | Marcelo Mamede, Paolo Castellucci, Francesco Ceci, Riccardo Schiavina, Stefano Boschi, Valentina ...Ambrosini, Chiara Fuccio, Annarita Ianniello, Rossella Ferrara, Stefano Fanti | 2012-01-01 | THE JOURNAL OF NUCLEAR MEDICINE | - | 4.02 Riassunto (Abstract) | - |
| 18F-FDG PET early after radiotherapy in lymphoma patients. | CASTELLUCCI P; ZINZANI P; NANNI C; FARSAD M; MORETTI A; ALINARI L; BATTISTA G; PETTINATO C; MAREN...GO M; BOSCHI S; CANINI R; BACCARANI M.; MONETTI N; FANTI S. | 2004-01-01 | CANCER BIOTHERAPY & RADIOPHARMACEUTICALS | - | 1.01 Articolo in rivista | - |
| [18F]F-PSMA-1007 Radiolabelling without an On-Site Cyclotron: A Quality Issue | Di Iorio, Valentina; Boschi, Stefano; Sarnelli, Anna; Cuni, Cristina; Bianchini, David; Monti, Ma...nuela; Gorgoni, Giancarlo; Paganelli, Giovanni; Matteucci, Federica; Masini, Carla | 2021-01-01 | PHARMACEUTICALS | - | 1.01 Articolo in rivista | - |
| Advances in preclinical therapeutics development using small animal imaging and molecular analyses: the gastrointestinal stromal tumors model. | M.A. Pantaleo; L. Landuzzi; G. Nicoletti; C. Nanni; S. Boschi; G. Piazzi; D. Santini; M. Di Batti...sta; P. Castellucci; F. Lodi; S. Fanti; P.-L. Lollini; G. Biasco | 2009-01-01 | CLINICAL AND EXPERIMENTAL MEDICINE | - | 1.01 Articolo in rivista | - |
| An HPLC and UHPLC-HRMS approach to study PSMA-11 instability in aqueous solution | Iudicello, Antonella; Genovese, Filippo; Di Iorio, Valentina; Cicoria, Gianfranco; Boschi, Stefano | 2021-01-01 | EJNMMI RADIOPHARMACY AND CHEMISTRY | - | 1.01 Articolo in rivista | - |
| Bioavailability of single and multiple doses of a new oral formulation of 5‐ASA in patients with inflammatory bowel disease and healthy volunteers | GIONCHETTI P.; CAMPIERI M.; BELLUZZI A.; BOSCHI S.; BRIGNOLA C.; MIGLIOLI M.; BARBARA L. | 1994-01-01 | ALIMENTARY PHARMACOLOGY & THERAPEUTICS | - | 1.01 Articolo in rivista | - |
| C-11 Acetate does not enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma. | Magini G; Farsad M; Frigerio M; Serra C; Colecchia A; Jovine E; Vivarelli M; Feletti V; Golfieri ...R; Patti C; Fanti S; Franchi R; Lodi F; Boschi S; Bernardi M; Trevisani F. | 2009-01-01 | CLINICAL NUCLEAR MEDICINE | - | 1.01 Articolo in rivista | - |
| Comparison of 18F-FACBC and 11C-choline PET/CT in patients with radically treated prostate cancer and biochemical relapse: preliminary results | Cristina Nanni; Riccardo Schiavina; Stefano Boschi; Valentina Ambrosini; Cinzia Pettinato; Eugeni...o Brunocilla; Giuseppe Martorana; Stefano Fanti | 2013-01-01 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 1.01 Articolo in rivista | - |
| Conventional and novel PET tracers for imaging in oncology in the era of molecular therapy. Review | Pantaleo M.A.; Nannini M.; Maleddu A.; Fanti S.; Ambrosini V.; Nanni C.; Boschi S.; Biasco G. | 2008-01-01 | CANCER TREATMENT REVIEWS | - | 1.01 Articolo in rivista | - |
| Detection and localization of prostate cancer: correlation of (11)C-choline PET/CT with histopathologic step-section analysis | Farsad M; Schiavina R; Castellucci P; Nanni C; Corti B; Martorana G; Canini R; Grigioni W; Boschi... S; Marengo M; Pettinato C; Salizzoni E; Monetti N; Franchi R; Fanti S. | 2005-01-01 | THE JOURNAL OF NUCLEAR MEDICINE | - | 1.01 Articolo in rivista | - |
| Effects of new fish oil derivative on fatty acid phospholipid-membrane pattern in a group of Crohn's disease patients | Belluzzi A.; Brignola C.; Campieri M.; Camporesi E.P.; Gionchetti P.; Rizzello F.; Belloli C.; De... Simone G.; Boschi S.; Miglioli M.; Barbara L. | 1994-01-01 | DIGESTIVE DISEASES AND SCIENCES | - | 1.01 Articolo in rivista | - |
| Evaluation of Modified PEG-Anilinoquinazoline Derivatives as Potential Agents for EGFR Imaging in Cancer by Small Animal PET. | Pantaleo M.A.; Mishani E.; Nanni C.; Landuzzi L.; Boschi S.; Nicoletti G.; Dissoki S.; Paterini P....; Piccaluga P.P.; Lodi F.; Lollini P.L.; Fanti S.; Biasco G. | 2010-01-01 | MOLECULAR IMAGING AND BIOLOGY | - | 1.01 Articolo in rivista | - |
| Experimental results and related clinical implications of PET detection of epidermal growth factor receptor (EGFr) in cancer | M.A. Pantaleo; M. Nannini; A. Maleddu; S. Fanti; C. Nanni; S. Boschi; F. Lodi; G. Nicoletti; L. L...anduzzi; P. L. Lollini; G. Biasco | 2009-01-01 | ANNALS OF ONCOLOGY | - | 1.01 Articolo in rivista | - |
| From radiotracer to radiopharmaceutical: a philosophical approach | Boschi, Stefano; Todde, Sergio | 2021-01-01 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 1.01 Articolo in rivista | - |
| Functional imaging of digestive endocrine tumors. | Fanti S.; Nanni C.; Ambrosini V.; Campana D.; Montini G.C.; Castellucci P.; Di Piezzo D.; Rubello... D.; Allegri V.; Tomassetti P.; Boschi S.; Franchi R. | 2007-01-01 | JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION | - | 1.01 Articolo in rivista | - |
| Ga-68-PSMA PET/CT for early restaging prostate cancer. Preliminary results of a prospective trial in patients with biochemical failure after radical therapy and PSA levels< 2 ng/mL | francesco ceci; castellucci paolo; tiziano graziani; cristina fonti; filippo lodi; stefano boschi...; stefano fanti | 2016-01-01 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 1.06 Abstract in rivista | - |
| Generator breakthrough and radionuclidic purification in automated synthesis of 68Ga-DOTANOC | Belosi F; Cicoria G; Lodi F; Malizia C; Fanti S; Boschi S; Marengo M. | 2013-01-01 | CURRENT RADIOPHARMACEUTICALS | - | 1.01 Articolo in rivista | - |
| Is there a role for 11C-choline PET/CT in the early detection of metastatic disease in surgically treated prostate cancer patients with a mild PSA increase <1.5 ng/ml? | Castellucci P.; Fuccio C.; Rubello D.; Schiavina R.; Santi I.; Nanni C.; Allegri V.; Montini G.C....; Ambrosini V.; Boschi S.; Martorana G.; Marzola M.C.; Fanti S. | 2011-01-01 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 1.01 Articolo in rivista | - |
| Molecular imaging and targeted therapies in oncology: new concepts in treatment response assessment. a collection of cases. | Pantaleo MA;Nannini M;Lopci E;Castellucci P;Maleddu A;Lodi F;Nanni C;Allegri V;Astorino M;Brandi ...G;Di Battista M;Boschi S;Fanti S;Biasco G | 2008-01-01 | INTERNATIONAL JOURNAL OF ONCOLOGY | - | 1.01 Articolo in rivista | - |